Skip to main content
. 2023 Jan 31;13:1048593. doi: 10.3389/fonc.2023.1048593

Table 4.

Study flowchart.

Procedure/evaluation Randomization Continuous
(up to 24 months from study entry)
Months +6, +12, +18, +24
( ± 2 weeks)
Informed consent
Baseline evaluation
Randomization
Demographics
Concomitant medications and medical events review
Clinical data retrieval (stage, pathology, HPV status)
Physical/emotional/social monitoring apps ✓*
QoL questionnaires

*for intervention arm only.